Natixis Advisors LLC Buys 1,565 Shares of Stericycle, Inc. (NASDAQ:SRCL)

Natixis Advisors LLC lifted its stake in shares of Stericycle, Inc. (NASDAQ:SRCL) by 12.1% in the third quarter, according to its most recent filing with the SEC. The fund owned 14,489 shares of the business services provider’s stock after acquiring an additional 1,565 shares during the period. Natixis Advisors LLC’s holdings in Stericycle were worth $884,000 as of its most recent SEC filing.

A number of other hedge funds also recently made changes to their positions in SRCL. Pentwater Capital Management LP bought a new stake in shares of Stericycle during the 2nd quarter worth $83,010,000. Magnetar Financial LLC bought a new stake in Stericycle in the second quarter worth $81,596,000. Millennium Management LLC lifted its stake in Stericycle by 1,057.6% in the second quarter. Millennium Management LLC now owns 1,315,274 shares of the business services provider’s stock worth $76,457,000 after purchasing an additional 1,201,653 shares during the last quarter. Alpine Associates Management Inc. bought a new stake in Stericycle in the second quarter worth $62,298,000. Finally, Nuance Investments LLC bought a new stake in Stericycle in the second quarter worth $37,263,000. 98.82% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Separately, StockNews.com initiated coverage on shares of Stericycle in a research note on Thursday. They issued a “hold” rating for the company. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $74.00.

Stericycle Price Performance

SRCL stock opened at $61.98 on Thursday. The firm’s 50-day moving average price is $61.40 and its two-hundred day moving average price is $58.58. Stericycle, Inc. has a 12-month low of $37.78 and a 12-month high of $61.99. The stock has a market capitalization of $5.75 billion, a price-to-earnings ratio of 163.11, a PEG ratio of 3.38 and a beta of 1.10. The company has a current ratio of 1.20, a quick ratio of 1.13 and a debt-to-equity ratio of 0.53.

About Stericycle

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.